Potential Link Between Sweetener Intake and Early Puberty Risk in Children
New research suggests that consuming artificial sweeteners may increase the risk of early puberty in children, especially those with genetic predispositions. The study highlights the importance of moderating sweetener intake to support healthy development.
Recent research presented at ENDO 2025, the annual meeting of the Endocrine Society, highlights a concerning connection between the consumption of certain artificial sweeteners and the increased risk of early puberty in children. The study, conducted in Taiwan and involving data from over 1,400 adolescents, indicates that children who consume sweeteners such as aspartame, sucralose, glycyrrhizin, and added sugars are more likely to develop central precocious puberty, especially if they carry specific genetic traits.
Central precocious puberty is a condition where physical and hormonal changes of puberty occur earlier than usual, which can lead to emotional challenges, shorter adult stature, and higher risks of metabolic and reproductive health issues later in life.
The researchers found that the quantity of sweeteners intake correlates positively with the risk of early puberty. Notably, sucralose consumption was linked to higher risks in boys, while in girls, glycyrrhizin, sucralose, and added sugars showed similar associations. Children with certain genetic predispositions were more vulnerable to these effects.
This study builds on previous findings by Dr. Yang Ching Chen, which demonstrated that artificial sweeteners could influence hormones and gut bacteria tied to puberty onset. For instance, acesulfame potassium (AceK) was shown to activate pathways in brain cells that promote puberty hormones, while glycyrrhizin can alter gut bacteria and reduce gene activity related to puberty regulation.
The findings suggest that dietary habits involving sweeteners may significantly impact normal developmental processes. The Taiwanese study used questionnaires, urine tests, genetic risk scoring, and medical assessments to draw these conclusions. Significantly, monitoring and moderating sweetener intake, alongside genetic screening, could be powerful strategies to prevent premature puberty and its associated health issues.
The research emphasizes the importance of awareness among parents, healthcare providers, and policymakers regarding the potential effects of artificial and added sugars in children's diets. It underscores the need for updated dietary guidelines and risk assessment tools to promote healthier developmental trajectories in youth.
Source: https://medicalxpress.com/news/2025-07-consuming-sweeteners-early-puberty.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Impact of Losing Health Insurance on Your Primary Doctor and Overall Well-Being
Losing health insurance can break vital links to your primary care provider, leading to worse health outcomes and higher healthcare costs. Maintaining coverage ensures preventive care, early diagnosis, and ongoing health management.
How External Cues and Treatment Expectations Influence Pain Perception Differently, Study Shows
New research reveals that external cues and treatment expectations influence pain perception through different brain mechanisms, highlighting the importance of communication in pain management.
Could Caffeine Play a Role in Preventing Sudden Infant Death Syndrome?
Research suggests caffeine might help prevent Sudden Infant Death Syndrome by counteracting low oxygen episodes in infants. This innovative hypothesis could open new pathways for prevention strategies in infant health.
Revolutionary Genetic Test Can Diagnose Brain Tumors in Just Two Hours
A groundbreaking genetic testing method can diagnose brain tumors in as little as two hours, vastly improving intraoperative decision-making and patient outcomes. Developed by the University of Nottingham, this technology uses nanopore sequencing to provide quick, accurate, and cost-effective tumor classification, transforming care for brain cancer patients.